Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMT Type 2
…that can cause type 2 include: CMT2A, CMT2A2B, CMT2B4, HMSN6A – Mitofusin 2 (MFN2) CMT2B – Members RAS oncogene family (RAB7 or RAB7A) CMT2B1 – Lamin A/C (LMNA) CMT2B2 –…
CMTA Staff
…(STAR) and STAR Advisory Board, a group of 30 of the world’s leading CMT clinicians and scientists charged with shaping and delivering the CMTA’s research strategies. CMTA currently has more…
CMT Type 1
Charcot-Marie-Tooth disease Type 1 (CMT1) What is CMT Type 1? CMT Type 1 (CMT1) is defined as an autosomal dominant (see inheritance) demyelinating form of CMT. CMT1 accounts for about…
CMTAreportspring24FINALwebSPREADS
…Study (all CMT subtypes) • Finding Your Gene—The Distant Cousin Project • Biomarkers and Outcome Measures (CMT1B, CMTX1 (aka CMT1X/CMTX), CMT2A, CMT2F) • The Inherited Neuropathies Consortium (INC) Study 6601:…
CMTA-STAR Biotech & Alliance Partners
…RESEARCH FOR DEMYELINATING CMT (Click image to enlarge) RESEARCH FOR AXONAL CMT CMTA-STAR ALLIANCE PARTNERS Actio Biosciences Actio Biosciences was founded by leaders in genetics and drug development to push…
Genes, Genetics and Genealogy: Three Roadmaps for CMT
…of autosomal dominant CMT Type 2T, characterized by late-onset axonal CMT, usually starting around age 50. Finally, I knew—2T. Four generations of my family have had CMT symptoms consistent with…
Tratamiento y Gestión de CMT
Tratamiento y Gestión de CMT El tratamiento de laCMT se hace en conjunto con los profesionales médicos de distintas especialidades. Después del diagnóstico por un neurólogo, los pacientes de CMT…
CMTAWinter2023webspreads
…CMT2, CMT4, CMTX, dominant intermediate CMT (CMTDI), recessive intermediate CMT (CMTRI), distal hereditary motor neuropathy (dHMN), distal spinal muscular atrophy (dSMA), giant axonal neuropathy (GAN), hereditary motor and sensory neuropathy…
CMTA Report_Winter 2024 – STAR Special Edition_Download
…Toolbox iPSC Licensee CMTA-STAR Advisory Board Member CMTA-STAR Funded Researcher CMTA Center of Excellence INC-Affiliated CMTA Center of Excellence Aarhus, Denmark Drug Developer, CMTA-STAR Alliance Partner, Conducting CMT-SYNAPSE Clinical Trial…
What’s New in CMT Research and Care? A 2025 Update Published by CMTA-STAR Advisory Board Member Davide Pareyson, MD
…proper care and treatment planning. Visit CMTA’s Diagnosing CMT page to learn more. Comprehensive Care: Managing CMT Today While there are no FDA-approved treatments for CMT, CMT specialists continue refining…